AI-generated summary
In this pilot study in mice, the authors examined transcranial photobiomodulation at 1267 nm and 32 J/cm2 on clearance of beta-amyloid from the brain. They report fewer amyloid plaques and better cognitive and memory test performance in treated animals compared with untreated ones. The authors describe a possible lymphatic clearance mechanism, but the study is a small pilot in mice.
- Who or what was studied
- Mice with Alzheimer's disease
- Wavelengths
- 1267 nm
- Limits stated in the abstract
- This is a small pilot study in mice, so the findings may not apply to humans and the sample size is not stated in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on opg.optica.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 1267 nm
- Energy density (fluence)
- 32 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Photobiomodulation, Pilot study. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.